SV2010003773A - 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos - Google Patents

7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos

Info

Publication number
SV2010003773A
SV2010003773A SV2010003773A SV2010003773A SV2010003773A SV 2010003773 A SV2010003773 A SV 2010003773A SV 2010003773 A SV2010003773 A SV 2010003773A SV 2010003773 A SV2010003773 A SV 2010003773A SV 2010003773 A SV2010003773 A SV 2010003773A
Authority
SV
El Salvador
Prior art keywords
same
sulfinilmetil
sulfanilmetil
sulfonilmetilindoles
replaced
Prior art date
Application number
SV2010003773A
Other languages
English (en)
Inventor
Peter Kolkhof
Astrid Bruens
Kai Thede
Karl Heinz Schlemmer
Armin Kern
Michael Gerisch
Andreas Goller
Alexander Hillisch
Dieter Lang
Rolf Grosser
Elisabeth Woltering
Holger Paulsen
Carsten Schmeck
Olaf Prien
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of SV2010003773A publication Critical patent/SV2010003773A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NUEVOS DERIVADOS DE 7-SULFANILMETIL-, 7-SULFINILMETIL- Y 7-SULFONILMETILINDOL, A PROCEDIMIENTOS PARA LA PREPARACIÓN DE LOS MISMOS, AL USO DE LOS MISMOS SOLOS O EN COMBINACIONES PARA EL TRATAMIENTO Y/O LA PREVENCIÓN DE ENFERMEDADES, Y AL USO DE LOS MISMOS PARA LA PREPARACIÓN DE MEDICAMENTOS PARA EL TRATAMIENTO Y/O LA PREVENCIÓN DE ENFERMEDADES, ESPECIALMENTE PARA EL TRATAMIENTO Y/O LA PREVENCIÓN DE ENFERMEDADES CARDIOVASCULARES
SV2010003773A 2008-06-25 2010-12-21 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos SV2010003773A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008030207A DE102008030207A1 (de) 2008-06-25 2008-06-25 Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung

Publications (1)

Publication Number Publication Date
SV2010003773A true SV2010003773A (es) 2011-08-29

Family

ID=41017186

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2010003773A SV2010003773A (es) 2008-06-25 2010-12-21 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos

Country Status (24)

Country Link
US (2) US20110201564A1 (es)
EP (1) EP2300423A1 (es)
JP (1) JP2011525504A (es)
KR (1) KR20110023895A (es)
CN (1) CN102131776A (es)
AR (1) AR072202A1 (es)
AU (1) AU2009262582A1 (es)
BR (1) BRPI0915405A2 (es)
CA (1) CA2729048A1 (es)
CL (1) CL2010001508A1 (es)
CO (1) CO6321237A2 (es)
CR (1) CR11869A (es)
DE (1) DE102008030207A1 (es)
DO (1) DOP2010000400A (es)
EC (1) ECSP10010711A (es)
IL (1) IL209718A0 (es)
MA (1) MA32416B1 (es)
MX (1) MX2010014447A (es)
PE (1) PE20110331A1 (es)
RU (1) RU2011102472A (es)
SV (1) SV2010003773A (es)
TW (1) TW201012800A (es)
UY (1) UY31903A (es)
WO (1) WO2009156072A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011137220A1 (en) * 2010-04-28 2011-11-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Small molecule neuropeptide s antagonists for the treatment of addictive disorders, mood, anxiety and sleep disorders
JP6078004B2 (ja) 2011-01-20 2017-02-08 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． ミネラルコルチコイド受容体拮抗薬
DE102011015126B4 (de) * 2011-03-25 2014-09-25 Airbus Operations Gmbh Flugzeugheckbereich mit einem in dem Flugzeugheckbereich installierten Kühlsystem
KR20170016754A (ko) * 2015-08-04 2017-02-14 씨제이헬스케어 주식회사 크로마논 유도체의 신규한 제조방법
KR101894091B1 (ko) * 2018-01-23 2018-08-31 씨제이헬스케어 주식회사 크로마논 유도체의 신규한 제조방법
CN111039873B (zh) * 2019-12-20 2022-03-15 河北美荷药业有限公司 一种芬苯达唑亚砜的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2778819A (en) 1950-08-21 1957-01-22 Bayer Ag 1-alkoxy-3 imino-isoindolenine derivatives
NL82464C (es) 1952-01-05
US2765320A (en) 1954-09-03 1956-10-02 Pittsburgh Plate Glass Co Preparation of 2, 3-dimethylindole
AU4649189A (en) 1988-11-14 1990-06-12 Upjohn Company, The Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
GB9609641D0 (en) 1996-05-09 1996-07-10 Pfizer Ltd Compounds useful in therapy
US5808064A (en) 1996-08-13 1998-09-15 Merck & Co., Inc. Palladium catalyzed indolization
ES2185983T3 (es) 1996-08-13 2003-05-01 Merck & Co Inc Indolizacion catalizada con paladio.
DE19834047A1 (de) 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
DE19943639A1 (de) 1999-09-13 2001-03-15 Bayer Ag Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
DE19943634A1 (de) 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
AR031176A1 (es) 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
DE10110749A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
DE10110750A1 (de) 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
BRPI0406883A (pt) 2003-01-22 2006-01-03 Lilly Co Eli Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
EP1723105B1 (en) 2004-03-03 2013-05-15 Eli Lilly And Company Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
MXPA06014018A (es) 2004-06-01 2007-02-08 Hoffmann La Roche 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas.
JPWO2007040166A1 (ja) 2005-09-30 2009-04-16 大日本住友製薬株式会社 新規な縮合ピロール誘導体
ES2368416T3 (es) 2005-11-30 2011-11-17 F. Hoffmann-La Roche Ag Procedimiento para la síntesis de 3-amino-1-arilpropil-indoles.
US7960544B2 (en) 2005-12-16 2011-06-14 Ironwood Pharmaceuticals, Inc. Useful indole compounds
CA2660704A1 (en) 2006-08-07 2008-02-14 Ironwood Pharmaceuticals, Inc. Indole compounds
TW201242961A (en) 2007-06-20 2012-11-01 Ironwood Pharmaceuticals Inc FAAH inhibitors

Also Published As

Publication number Publication date
KR20110023895A (ko) 2011-03-08
CN102131776A (zh) 2011-07-20
IL209718A0 (en) 2011-02-28
MA32416B1 (fr) 2011-06-01
PE20110331A1 (es) 2011-06-22
EP2300423A1 (de) 2011-03-30
MX2010014447A (es) 2011-01-21
CL2010001508A1 (es) 2011-05-06
DOP2010000400A (es) 2011-01-31
AU2009262582A1 (en) 2009-12-30
UY31903A (es) 2010-01-29
CR11869A (es) 2011-05-10
DE102008030207A1 (de) 2009-12-31
CO6321237A2 (es) 2011-09-20
TW201012800A (en) 2010-04-01
JP2011525504A (ja) 2011-09-22
US20110201564A1 (en) 2011-08-18
ECSP10010711A (es) 2011-01-31
BRPI0915405A2 (pt) 2015-11-03
US8063234B2 (en) 2011-11-22
US20100105744A1 (en) 2010-04-29
CA2729048A1 (en) 2009-12-30
AR072202A1 (es) 2010-08-11
RU2011102472A (ru) 2012-07-27
WO2009156072A1 (de) 2009-12-30

Similar Documents

Publication Publication Date Title
SV2009003098A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CL2014001158A1 (es) Compuestos derivados de piperazina alquilados; composicion farmaceutica que los comprende; proceso para preparar la composicion farmaceutica; kit y uso en el tratamiento de trastornos inmunes, cancer, enfermedades cardiovasculares, inflamacion, entre otros.
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
SV2010003451A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
UY31228A1 (es) Ariloxazoles sustituidos y su uso
BRPI0917315A2 (pt) anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
UY31922A (es) Compuestos
CL2013001338A1 (es) Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih.
DOP2014000255A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
CU20120171A7 (es) Triazolopiridinas sustituidas
SV2010003773A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
BRPI0913297A2 (pt) composição, farmacêutica, uso de uma composição, e, kit terapêutico.
SV2010003753A (es) Dronedarona para la prevencion de la cardioversion
UY33099A (es) Derivados de 9h-piridino[3,4-b]indol disustituidos, metodo para prepararlos, intermediarios de sintesis, composiciones farmaceuticas que los contienen y uso de los mismos en la terapia del cancer.
CU20100260A7 (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
NI201200162A (es) Inhibidores de pirazolil quinoxalina cinasa
CL2010000899A1 (es) N1-bencil-n8-hidroxi octanodiamida; composicion farmaceutica que comprende a dicho compuesto; combinacion farmaceutica que comprende a dicho compuesto; y su uso en el tratamiento de tumores.(divisional de la solicitud 1247-04).

Legal Events

Date Code Title Description
FD Lapse